Study of Dihydropyrimidine Dehydrogenase in Colorectal Cancer
Author Information
Author(s): HL McLeod, J Sludden, GI Murray, RA Keenan, Al Davidson, K Park, M Koruth, J Cassidy
Primary Institution: University of Aberdeen
Hypothesis
How does dihydropyrimidine dehydrogenase (DPD) activity vary in colorectal tumors compared to normal tissue?
Conclusion
DPD activity is highly variable in colorectal tumors and is generally lower than in adjacent normal tissue.
Supporting Evidence
- DPD activity was highly variable in all tissues studied.
- The median tumor-normal activity ratio was 0.76.
- PMNC DPD activity was correlated with tumor activity.
- DPD activity was significantly higher in normal tissue than in tumor.
- Only three specimens had a tumor-normal ratio greater than 2.
Takeaway
This study looked at how an enzyme that breaks down a cancer drug works in tumors and normal tissue, finding that tumors often break it down less.
Methodology
DPD activity was measured in tumor, adjacent normal tissue, and PMNCs from 63 patients undergoing surgery for colorectal cancer.
Limitations
The study did not evaluate the influence of tissue DPD activity on response to 5-FU therapy due to uniform post-operative therapy.
Participant Demographics
32 male and 31 female patients with a median age of 70 years, ranging from 32 to 87 years.
Statistical Information
P-Value
0.001
Statistical Significance
p<0.001
Want to read the original?
Access the complete publication on the publisher's website